Provided by Tiger Trade Technology Pte. Ltd.

Forte BioSciences Inc

29.66
+5.7824.20%
Post-market: 29.660.00000.00%19:20 EST
Volume:423.43K
Turnover:12.29M
Market Cap:371.55M
PE:-6.75
High:30.50
Open:23.63
Low:23.63
Close:23.88
52wk High:31.27
52wk Low:4.90
Shares:12.53M
Float Shares:9.26M
Volume Ratio:2.44
T/O Rate:4.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3909
EPS(LYR):-12.1671
ROE:-110.72%
ROA:-58.07%
PB:4.42
PE(LYR):-2.44

Loading ...

Company Profile

Company Name:
Forte BioSciences Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
16
Office Location:
3060 Pegasus Park Drive,Building 6,Dallas,Texas,United States
Zip Code:
75247
Fax:
- -
Introduction:
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Directors

Name
Position
Faheem Hasnain
Director and Chairman of the Board
Martin J. Duvall
Director and Chief Executive Officer
Harry E. Gruber
Director and President, Science and Innovation
David Parkinson
Director
Franklin M. Berger
Director
Lori Kunkel
Director
Paul Schimmel
Director
Thomas E. Darcy
Director

Shareholders

Name
Position
Martin J. Duvall
Director and Chief Executive Officer
Asha Das
Senior Vice President and Chief Medical Officer
Mark Foletta
Executive Vice President and Chief Financial Officer
Douglas Jolly
Executive Vice President, Research and Pharmaceutical Development
Harry E. Gruber
Director and President, Science and Innovation